Thoma Bravo, a software investment firm, has made an investment in Logex, a European healthcare analytics company.

Logex is a healthcare analytics provider that uses data to help healthcare providers and hospitals with decisions and to help deliver health outcomes for patients while aiming to reduce costs. Founded in 2008 and headquartered in Amsterdam, Logex is active in 10 countries and looks to expand further across Europe. Logex’s existing shareholders, the company’s founders and Summa Equity will remain invested with the business and will work with Thoma Bravo and the executive committee to support Logex’s European growth and services in healthcare analytics.

“There is an urgent need for stronger, more resilient, and more accessible health systems in Europe,” comments Philipp Jan Flach, chief executive officer at Logex. “We are already active in 10 European markets and we know we can play a meaningful role in evolving healthcare in Europe and making systems interoperable for improved international collaboration if we can expand further. Thoma Bravo, with their deep technical knowledge and their expertise in operational excellence, will be a fantastic partner to help us achieve that goal.”

Jefferies LLC served as financial advisor to LOGEX and Allen & Overy served as legal counsel. Kirkland & Ellis LLP served as legal counsel to Thoma Bravo and Harris Williams & Co. Ltd served as Thoma Bravo’s financial advisor.